The importance of pharmacokinetics, pharmacodynamic and repetitive use of levosimendan
2022 · Biomedicine & Pharmacotherapy · 23 citations
https://doi.org/10.1016/j.biopha.2022.113391
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
296
Citations
10
h-index
10
i10-index
Daniel Rogowicz is an academic researcher from Nicolaus Copernicus University. The author has contributed to research in topics: Heart Failure Treatment and Management & Atrial Fibrillation Management and Outcomes & Venous Thromboembolism Diagnosis and Management. The author has an h-index of 10, co-authored 27 publications.
ORCID: 0000-0001-8440-902Xhttps://doi.org/10.1016/j.biopha.2022.113391
https://doi.org/10.1007/s11845-023-03285-x
Click to start Chat